Company Filing History:
Years Active: 2024-2025
Title: Rani Mahmoudi: Innovator in Pediatric Cardiology
Introduction
Rani Mahmoudi is a notable inventor based in Huntington Beach, California. He has made significant contributions to the field of pediatric cardiology through his innovative designs and patents. With a total of three patents to his name, Mahmoudi is dedicated to improving treatment options for congenital heart diseases in infants and children.
Latest Patents
One of Rani Mahmoudi's latest patents is focused on transcatheter growth devices and methods for Norwood, Glenn, and Fontan therapy. This transcatheter growth device is designed to treat congenital illnesses in pediatric heart disease patients. The device features an elongated frame with alternating annular growth cell members and spacing members that span the proximal and distal ends. Each growth cell member is designed with scaffolded structures that provide flexibility to the device frame. Additionally, the device includes a retention member for engaging a selected lumen within a patient and a covering member for sealing the device when deployed. This innovative growth device can be utilized alone or in combination with other growth devices to effectively treat heart disease.
Career Highlights
Rani Mahmoudi has established himself as a key figure in the medical device industry, particularly in the development of solutions for pediatric heart conditions. His work at Renata Medical, Inc. has allowed him to collaborate with other professionals in the field and contribute to advancements in medical technology.
Collaborations
Some of Rani Mahmoudi's coworkers include Corey Marshall and Eason Michael Abbott. Their collaborative efforts have further enhanced the development of innovative medical devices aimed at improving patient outcomes.
Conclusion
Rani Mahmoudi's contributions to pediatric cardiology through his innovative patents and collaborative work highlight his commitment to advancing medical technology. His inventions are paving the way for better treatment options for children suffering from congenital heart diseases.